Bottom line
Is PTH a good fund? The bottom line
PTH is a managed health care sector ETF from Invesco.
Its expense ratio is 0.6% — about $60 a year on every $10,000 invested, cheaper than 77% of health care sector funds we track.
It returned +28.1% over one year, −0.8% a year over five years, +10.8% a year over ten (as of Dec 31, 2025, per its prospectus).
With $235 million in net assets and 57 holdings, its largest position is Invesco Private Prime Fund (20.8%) and the top 10 make up 59.3% of the portfolio.
What stands out
- Low cost: cheaper than 77% of health care sector peers
What to watch
- 5-year return in the bottom quarter of its category
- Concentrated: top 10 holdings are 59.3% of assets
- High turnover (239% a year) can mean more taxable distributions
Updated Nov 19, 2026
What PTH invests in
The Invesco Dorsey Wright Healthcare Momentum ETF (the Fund) seeks to track the investment results (before fees and expenses) of the Dorsey Wright Healthcare Technical Leaders TM Index (the Underlying Index).
The Fund is an index fund that seeks to track the investment results of the Underlying Index. Strictly in accordance with its guidelines and mandated procedures, Dorsey, Wright & Associates, LLC (Dorsey Wright or the Index Provider) compiles and maintains the Underlying Index, which is composed of at least 30 securities of companies in the health care sector that have powerful relative strength or momentum characteristics. Dorsey Wright selects these securities from 2,000 of the largest constituents by market capitalization within the Nasdaq US Benchmark Index, a float adjusted market capitalization-weighted index designed to track the performance of the U.S. equity market. Relative strength is an investing technique that seeks to determine the strongest performing securities by measuring certain factors, such as a securitys relative performance against the overall market over a set…
From the fund's prospectus (filed Aug 27, 2026).
PTH performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| PTH | +28.1% | −0.8% | +10.8% |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2025
What PTH costs
On a $10,000 investment, PTH's 0.6% expense ratio costs about $60 a year. The prospectus estimates $891 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
PTH top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Invesco Private Prime Fund | 20.79% |
| 2 | Invesco Private Government Fund | 6.84% |
| 3 | Guardant Health, Inc. | 4.97% |
| 4 | Roivant Sciences Ltd. | 4.95% |
| 5 | Revolution Medicines, Inc. | 4.94% |
| 6 | Axsome Therapeutics, Inc. | 4.12% |
| 7 | BrightSpring Health Services, Inc. | 4.03% |
| 8 | Liquidia Corp. | 3.01% |
| 9 | Erasca, Inc. | 2.94% |
| 10 | Oruka Therapeutics, Inc. | 2.74% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 59.3% of the fund. See all top 25 holdings and asset mix →